RPL22L1 and posterior cortical atrophy: Further results showed that LY294002, an inhibitor of PI3K/Akt pathway, was able to significantly attenuate the oncogenic effect of RPL22L1 on PCa cell proliferation and invasion, suggesting that RPL22L1 promoted PCa progression mainly by PI3K/Akt/mTOR pathway.